Results 121 to 130 of about 7,496 (162)

Red Blood Cell Depletion in Patients With Hyperferritinemia: Comparison of Two Apheresis Systems. [PDF]

open access: yesJ Clin Apher
Neureiter H   +6 more
europepmc   +1 more source

A rare case report of decompensated cirrhosis from hereditary hemochromatosis following lung transplant in a person with cystic fibrosis. [PDF]

open access: yesRespir Med Case Rep
Joo E   +9 more
europepmc   +1 more source

Emerging Significance and Implications of a Durable Complete Molecular Remission in the Treatment of Polycythemia Vera. [PDF]

open access: yesCurr Hematol Malig Rep
Duan M   +7 more
europepmc   +1 more source

Therapeutic Phlebotomy in Patients with Grade 1 Hypertension: A Randomized-Controlled Trial

Journal of Integrative and Complementary Medicine, 2022
Aim: Study aim was to investigate the effects of therapeutic phlebotomy on ambulatory blood pressure in patients with grade 1 hypertension. Methods: In this randomized-controlled intervention study, patients with unmedicated hypertension grade 1 were randomized into an intervention group (phlebotomy group; 500 mL bloodletting at baseline and after 6 ...
Benno Brinkhaus   +2 more
exaly   +3 more sources

Therapeutic erythrocytapheresis versus phlebotomy in the initial treatment of hereditary hemochromatosis – A pilot study

Transfusion and Apheresis Science, 2007
Hereditary Hemochromatosis (HH) is a genetic disorder of iron metabolism, resulting in excessive iron overload. Currently, phlebotomy is the standard effective treatment that prevents progression of tissue damage. Aim of the therapy is to reach ferritin levels between 20 and 50mugl(-1).
Eva Rombout-Sestrienkova, Ger H Koek
exaly   +3 more sources

Home - About - Disclaimer - Privacy